Viewing Study NCT00743002


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2025-12-26 @ 2:24 AM
Study NCT ID: NCT00743002
Status: COMPLETED
Last Update Posted: 2013-06-21
First Post: 2008-08-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione
Sponsor: OPKO Health, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module